{
  "DOI": "10.1038/ejhg.2009.160",
  "ISSN": [
    "1018-4813",
    "1476-5438"
  ],
  "URL": "http://dx.doi.org/10.1038/ejhg.2009.160",
  "alternative-id": [
    "BFejhg2009160"
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Aartsma-Rus",
      "given": "Annemieke",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "van Ommen",
      "given": "Gert-Jan B",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "European Journal of Human Genetics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": []
  },
  "created": {
    "date-parts": [
      [
        2009,
        10,
        7
      ]
    ],
    "date-time": "2009-10-07T10:20:43Z",
    "timestamp": 1254910843000
  },
  "deposited": {
    "date-parts": [
      [
        2023,
        5,
        18
      ]
    ],
    "date-time": "2023-05-18T16:57:59Z",
    "timestamp": 1684429079000
  },
  "indexed": {
    "date-parts": [
      [
        2023,
        12,
        24
      ]
    ],
    "date-time": "2023-12-24T14:51:54Z",
    "timestamp": 1703429514511
  },
  "is-referenced-by-count": 30,
  "issn-type": [
    {
      "type": "print",
      "value": "1018-4813"
    },
    {
      "type": "electronic",
      "value": "1476-5438"
    }
  ],
  "issue": "2",
  "issued": {
    "date-parts": [
      [
        2009,
        10,
        7
      ]
    ]
  },
  "journal-issue": {
    "issue": "2",
    "published-print": {
      "date-parts": [
        [
          2010,
          2
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "http://www.springer.com/tdm",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2009,
            10,
            7
          ]
        ],
        "date-time": "2009-10-07T00:00:00Z",
        "timestamp": 1254873600000
      }
    }
  ],
  "link": [
    {
      "URL": "http://www.nature.com/articles/ejhg2009160.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://www.nature.com/articles/ejhg2009160",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://www.nature.com/articles/ejhg2009160.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "146-153",
  "prefix": "10.1038",
  "published": {
    "date-parts": [
      [
        2009,
        10,
        7
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2009,
        10,
        7
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2010,
        2
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1016/S0140-6736(02)07815-7",
      "author": "AE Emery",
      "doi-asserted-by": "publisher",
      "first-page": "687",
      "journal-title": "Lancet",
      "key": "BFejhg2009160_CR1",
      "unstructured": "Emery AE : The muscular dystrophies. Lancet 2002; 359: 687–695.",
      "volume": "359",
      "year": "2002"
    },
    {
      "DOI": "10.1038/nrg1180",
      "author": "JC van Deutekom",
      "doi-asserted-by": "publisher",
      "first-page": "774",
      "journal-title": "Nat Rev Genet",
      "key": "BFejhg2009160_CR2",
      "unstructured": "van Deutekom JC, van Ommen GJ : Advances in Duchenne muscular dystrophy gene therapy. Nat Rev Genet 2003; 4: 774–783.",
      "volume": "4",
      "year": "2003"
    },
    {
      "author": "LM Judge",
      "first-page": "184",
      "journal-title": "Acta Myol",
      "key": "BFejhg2009160_CR3",
      "unstructured": "Judge LM, Chamberlain JS : Gene therapy for Duchenne muscular dystrophy: AAV leads the way. Acta Myol 2005; 24: 184–193.",
      "volume": "24",
      "year": "2005"
    },
    {
      "key": "BFejhg2009160_CR4",
      "unstructured": "Antisense Drug Technology: Principles, Strategies, and Applications. New York: Marcel Dekker Inc., 2001."
    },
    {
      "DOI": "10.1016/j.ajhg.2008.01.014",
      "author": "Y Hua",
      "doi-asserted-by": "publisher",
      "first-page": "834",
      "journal-title": "Am J Hum Genet",
      "key": "BFejhg2009160_CR5",
      "unstructured": "Hua Y, Vickers TA, Okunola HL, Bennett CF, Krainer AR : Antisense masking of an hnRNP A1/A2 intronic splicing silencer corrects SMN2 splicing in transgenic mice. Am J Hum Genet 2008; 82: 834–848.",
      "volume": "82",
      "year": "2008"
    },
    {
      "DOI": "10.1016/j.molcel.2007.01.031",
      "author": "J Krol",
      "doi-asserted-by": "publisher",
      "first-page": "575",
      "journal-title": "Mol Cell",
      "key": "BFejhg2009160_CR6",
      "unstructured": "Krol J, Fiszer A, Mykowska A, Sobczak K, de Mezer M, Krzyzosiak WJ : Ribonuclease dicer cleaves triplet repeat hairpins into shorter repeats that silence specific targets. Mol Cell 2007; 25: 575–586.",
      "volume": "25",
      "year": "2007"
    },
    {
      "DOI": "10.1056/NEJMoa073108",
      "author": "JC van Deutekom",
      "doi-asserted-by": "publisher",
      "first-page": "2677",
      "journal-title": "N Engl J Med",
      "key": "BFejhg2009160_CR7",
      "unstructured": "van Deutekom JC, Janson AA, Ginjaar IB et al: Local dystrophin restoration with antisense oligonucleotide PRO051. N Engl J Med 2007; 357: 2677–2686.",
      "volume": "357",
      "year": "2007"
    },
    {
      "author": "TM Wheeler",
      "first-page": "3952",
      "journal-title": "J Clin Invest",
      "key": "BFejhg2009160_CR8",
      "unstructured": "Wheeler TM, Lueck JD, Swanson MS, Dirksen RT, Thornton CA : Correction of ClC-1 splicing eliminates chloride channelopathy and myotonia in mouse models of myotonic dystrophy. J Clin Invest 2007; 117: 3952–3957.",
      "volume": "117",
      "year": "2007"
    },
    {
      "DOI": "10.1056/NEJMe0707795",
      "author": "EP Hoffman",
      "doi-asserted-by": "publisher",
      "first-page": "2719",
      "journal-title": "N Engl J Med",
      "key": "BFejhg2009160_CR9",
      "unstructured": "Hoffman EP : Skipping toward personalized molecular medicine. N Engl J Med 2007; 357: 2719–2722.",
      "volume": "357",
      "year": "2007"
    },
    {
      "DOI": "10.1371/journal.pbio.0050073",
      "author": "Y Hua",
      "doi-asserted-by": "publisher",
      "first-page": "e73",
      "journal-title": "PLoS Biol",
      "key": "BFejhg2009160_CR10",
      "unstructured": "Hua Y, Vickers TA, Baker BF, Bennett CF, Krainer AR : Enhancement of SMN2 exon 7 inclusion by antisense oligonucleotides targeting the exon. PLoS Biol 2007; 5: e73.",
      "volume": "5",
      "year": "2007"
    },
    {
      "DOI": "10.1016/0092-8674(87)90579-4",
      "author": "EP Hoffman",
      "doi-asserted-by": "publisher",
      "first-page": "919",
      "journal-title": "Cell",
      "key": "BFejhg2009160_CR11",
      "unstructured": "Hoffman EP, Brown Jr RH, Kunkel LM : Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 1987; 51: 919–928.",
      "volume": "51",
      "year": "1987"
    },
    {
      "DOI": "10.1016/0888-7543(88)90113-9",
      "author": "AP Monaco",
      "doi-asserted-by": "publisher",
      "first-page": "90",
      "journal-title": "Genomics",
      "key": "BFejhg2009160_CR12",
      "unstructured": "Monaco AP, Bertelson CJ, Liechti-Gallati S, Moser H, Kunkel LM : An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locus. Genomics 1988; 2: 90–95.",
      "volume": "2",
      "year": "1988"
    },
    {
      "DOI": "10.1136/jnnp.2007.141721",
      "author": "M Kohler",
      "doi-asserted-by": "publisher",
      "first-page": "320",
      "journal-title": "J Neurol Neurosurg Psychiatry",
      "key": "BFejhg2009160_CR13",
      "unstructured": "Kohler M, Clarenbach CF, Bahler C, Brack T, Russi EW, Bloch KE : Disability and survival in Duchenne muscular dystrophy. J Neurol Neurosurg Psychiatry 2009; 80: 320–325.",
      "volume": "80",
      "year": "2009"
    },
    {
      "DOI": "10.1002/mus.20812",
      "author": "C Angelini",
      "doi-asserted-by": "publisher",
      "first-page": "424",
      "journal-title": "Muscle Nerve",
      "key": "BFejhg2009160_CR14",
      "unstructured": "Angelini C : The role of corticosteroids in muscular dystrophy: a critical appraisal. Muscle Nerve 2007; 36: 424–435.",
      "volume": "36",
      "year": "2007"
    },
    {
      "DOI": "10.1056/NEJM198805263182104",
      "author": "EP Hoffman",
      "doi-asserted-by": "publisher",
      "first-page": "1363",
      "journal-title": "N Engl J Med",
      "key": "BFejhg2009160_CR15",
      "unstructured": "Hoffman EP, Fischbeck KH, Brown RH et al: Characterization of dystrophin in muscle-biopsy specimens from patients with Duchenne's or Becker's muscular dystrophy. N Engl J Med 1988; 318: 1363–1368.",
      "volume": "318",
      "year": "1988"
    },
    {
      "DOI": "10.1093/hmg/ddg100",
      "author": "A Aartsma-Rus",
      "doi-asserted-by": "publisher",
      "first-page": "907",
      "journal-title": "Hum Mol Genet",
      "key": "BFejhg2009160_CR16",
      "unstructured": "Aartsma-Rus A, Janson AA, Kaman WE et al: Therapeutic antisense-induced exon skipping in cultured muscle cells from six different DMD patients. Hum Mol Genet 2003; 12: 907–914.",
      "volume": "12",
      "year": "2003"
    },
    {
      "DOI": "10.1086/381039",
      "author": "A Aartsma-Rus",
      "doi-asserted-by": "publisher",
      "first-page": "83",
      "journal-title": "Am J Hum Genet",
      "key": "BFejhg2009160_CR17",
      "unstructured": "Aartsma-Rus A, Janson AA, Kaman WE et al: Antisense-induced multiexon skipping for duchenne muscular dystrophy makes more sense. Am J Hum Genet 2004; 74: 83–92.",
      "volume": "74",
      "year": "2004"
    },
    {
      "DOI": "10.1016/S0387-7604(01)00326-6",
      "author": "Y Takeshima",
      "doi-asserted-by": "publisher",
      "first-page": "788",
      "journal-title": "Brain Dev",
      "key": "BFejhg2009160_CR18",
      "unstructured": "Takeshima Y, Wada H, Yagi M et al: Oligonucleotides against a splicing enhancer sequence led to dystrophin production in muscle cells from a Duchenne muscular dystrophy patient. Brain Dev 2001; 23: 788–790.",
      "volume": "23",
      "year": "2001"
    },
    {
      "DOI": "10.1093/hmg/10.15.1547",
      "author": "JC van Deutekom",
      "doi-asserted-by": "publisher",
      "first-page": "1547",
      "journal-title": "Hum Mol Genet",
      "key": "BFejhg2009160_CR19",
      "unstructured": "van Deutekom JC, Bremmer-Bout M, Janson AA et al: Antisense-induced exon skipping restores dystrophin expression in DMD patient derived muscle cells. Hum Mol Genet 2001; 10: 1547–1554.",
      "volume": "10",
      "year": "2001"
    },
    {
      "DOI": "10.1002/humu.20918",
      "author": "A Aartsma-Rus",
      "doi-asserted-by": "publisher",
      "first-page": "293",
      "journal-title": "Hum Mutat",
      "key": "BFejhg2009160_CR20",
      "unstructured": "Aartsma-Rus A, Fokkema IF, Verschuuren JJ et al: Theoretic applicability of antisense-mediated exon skipping for Duchenne muscular dystrophy mutations. Hum Mutat 2009; 30: 293–299.",
      "volume": "30",
      "year": "2009"
    },
    {
      "DOI": "10.1089/1043034041648444",
      "author": "A Surono",
      "doi-asserted-by": "publisher",
      "first-page": "749",
      "journal-title": "Hum Gene Ther",
      "key": "BFejhg2009160_CR21",
      "unstructured": "Surono A, Van Khanh T, Takeshima Y et al: Chimeric RNA/ethylene-bridged nucleic acids promote dystrophin expression in myocytes of Duchenne muscular dystrophy by inducing skipping of the nonsense mutation-encoding exon. Hum Gene Ther 2004; 15: 749–757.",
      "volume": "15",
      "year": "2004"
    },
    {
      "DOI": "10.1002/jgm.1265",
      "author": "C Mitrpant",
      "doi-asserted-by": "publisher",
      "first-page": "46",
      "journal-title": "J Gene Med",
      "key": "BFejhg2009160_CR22",
      "unstructured": "Mitrpant C, Fletcher S, Iversen PL, Wilton SD : By-passing the nonsense mutation in the 4 CV mouse model of muscular dystrophy by induced exon skipping. J Gene Med 2009; 11: 46–56.",
      "volume": "11",
      "year": "2009"
    },
    {
      "DOI": "10.1038/nm897",
      "author": "QL Lu",
      "doi-asserted-by": "publisher",
      "first-page": "1009",
      "journal-title": "Nat Med",
      "key": "BFejhg2009160_CR23",
      "unstructured": "Lu QL, Mann CJ, Lou F et al: Functional amounts of dystrophin produced by skipping the mutated exon in the mdx dystrophic mouse. Nat Med 2003; 8: 1009–1014.",
      "volume": "8",
      "year": "2003"
    },
    {
      "DOI": "10.1038/sj.gt.3302800",
      "author": "G McClorey",
      "doi-asserted-by": "publisher",
      "first-page": "1373",
      "journal-title": "Gene Therapy",
      "key": "BFejhg2009160_CR24",
      "unstructured": "McClorey G, Moulton HM, Iversen PL, Fletcher S, Wilton SD : Antisense oligonucleotide-induced exon skipping restores dystrophin expression in vitro in a canine model of DMD. Gene Therapy 2006; 13: 1373–1381.",
      "volume": "13",
      "year": "2006"
    },
    {
      "DOI": "10.1517/14712598.7.6.831",
      "author": "T Yokota",
      "doi-asserted-by": "publisher",
      "first-page": "831",
      "journal-title": "Expert Opin Biol Ther",
      "key": "BFejhg2009160_CR25",
      "unstructured": "Yokota T, Pistilli E, Duddy W, Nagaraju K : Potential of oligonucleotide-mediated exon-skipping therapy for Duchenne muscular dystrophy. Expert Opin Biol Ther 2007; 7: 831–842.",
      "volume": "7",
      "year": "2007"
    },
    {
      "DOI": "10.1002/ana.21290",
      "author": "OL Gurvich",
      "doi-asserted-by": "publisher",
      "first-page": "81",
      "journal-title": "Ann Neurol",
      "key": "BFejhg2009160_CR26",
      "unstructured": "Gurvich OL, Tuohy TM, Howard MT et al: DMD pseudoexon mutations: splicing efficiency, phenotype, and potential therapy. Ann Neurol 2008; 63: 81–89.",
      "volume": "63",
      "year": "2008"
    },
    {
      "DOI": "10.1002/humu.20806",
      "author": "HR Madden",
      "doi-asserted-by": "publisher",
      "first-page": "22",
      "journal-title": "Hum Mutat",
      "key": "BFejhg2009160_CR27",
      "unstructured": "Madden HR, Fletcher S, Davis MR, Wilton SD : Characterization of a complex Duchenne muscular dystrophy-causing dystrophin gene inversion and restoration of the reading frame by induced exon skipping. Hum Mutat 2009; 30: 22–28.",
      "volume": "30",
      "year": "2009"
    },
    {
      "DOI": "10.1002/mus.20586",
      "author": "A Aartsma-Rus",
      "doi-asserted-by": "publisher",
      "first-page": "135",
      "journal-title": "Muscle Nerve",
      "key": "BFejhg2009160_CR28",
      "unstructured": "Aartsma-Rus A, van Deutekom JC, Fokkema IF, van Ommen GJ, den Dunnen JT : Entries in the Leiden Duchenne muscular dystrophy mutation database: an overview of mutation types and paradoxical cases that confirm the reading-frame rule. Muscle Nerve 2006; 34: 135–144.",
      "volume": "34",
      "year": "2006"
    },
    {
      "DOI": "10.1186/1471-2350-8-43",
      "author": "A Aartsma-Rus",
      "doi-asserted-by": "publisher",
      "first-page": "43",
      "journal-title": "BMC Med Genet",
      "key": "BFejhg2009160_CR29",
      "unstructured": "Aartsma-Rus A, Janson AA, van Ommen GJ, van Deutekom JC : Antisense-induced exon skipping for duplications in Duchenne muscular dystrophy. BMC Med Genet 2007; 8: 43.",
      "volume": "8",
      "year": "2007"
    },
    {
      "DOI": "10.4103/0028-3886.43443",
      "author": "SD Wilton",
      "doi-asserted-by": "publisher",
      "first-page": "254",
      "journal-title": "Neurol India",
      "key": "BFejhg2009160_CR30",
      "unstructured": "Wilton SD, Fletcher S : Exon skipping and Duchenne muscular dystrophy: hope, hype and how feasible? Neurol India 2008; 56: 254–262.",
      "volume": "56",
      "year": "2008"
    },
    {
      "DOI": "10.1089/oli.2005.15.284",
      "author": "A Aartsma-Rus",
      "doi-asserted-by": "publisher",
      "first-page": "284",
      "journal-title": "Oligonucleotides",
      "key": "BFejhg2009160_CR31",
      "unstructured": "Aartsma-Rus A, Winter CL, Janson AAM et al: Functional analysis of 114 exon-internal AONs for targeted DMD exon skipping: indication for steric hindrance of SR protein binding sites. Oligonucleotides 2005; 15: 284–297.",
      "volume": "15",
      "year": "2005"
    },
    {
      "DOI": "10.1038/sj.mt.6300095",
      "author": "SD Wilton",
      "doi-asserted-by": "publisher",
      "first-page": "1288",
      "journal-title": "Mol Ther",
      "key": "BFejhg2009160_CR32",
      "unstructured": "Wilton SD, Fall AM, Harding PL, McClorey G, Coleman C, Fletcher S : Antisense oligonucleotide-induced exon skipping across the human dystrophin gene transcript. Mol Ther 2007; 15: 1288–1296.",
      "volume": "15",
      "year": "2007"
    },
    {
      "DOI": "10.1016/j.nmd.2007.11.010",
      "author": "F Muntoni",
      "doi-asserted-by": "publisher",
      "first-page": "268",
      "journal-title": "Neuromuscul Disord",
      "key": "BFejhg2009160_CR33",
      "unstructured": "Muntoni F, Bushby KD, van Ommen G : 149th ENMC International Workshop and 1st TREAT-NMD Workshop on: ‘planning phase i/ii clinical trials using systemically delivered antisense oligonucleotides in duchenne muscular dystrophy’. Neuromuscul Disord 2008; 18: 268–275.",
      "volume": "18",
      "year": "2008"
    },
    {
      "author": "A Aartsma-Rus",
      "key": "BFejhg2009160_CR34",
      "unstructured": "Aartsma-Rus A, van Deutekom JC : Antisense-mediated reading-frame restoration as a genetic therapy for duchenne muscular dystrophy; in Hernandes AG (ed): Antisense Elements (Genetics) Research Focus. Nova publishers: Hauppauge, NY, USA, 2007.",
      "volume-title": "Antisense Elements (Genetics) Research Focus",
      "year": "2007"
    },
    {
      "DOI": "10.1038/nm1345",
      "author": "J Alter",
      "doi-asserted-by": "publisher",
      "first-page": "175",
      "journal-title": "Nat Med",
      "key": "BFejhg2009160_CR35",
      "unstructured": "Alter J, Lou F, Rabinowitz A . et al: Systemic delivery of morpholino oligonucleotide restores dystrophin expression bodywide and improves dystrophic pathology. Nat Med 2006; 12: 175–177.",
      "volume": "12",
      "year": "2006"
    },
    {
      "DOI": "10.1073/pnas.0406700102",
      "author": "QL Lu",
      "doi-asserted-by": "publisher",
      "first-page": "198",
      "journal-title": "Proc Natl Acad Sci USA",
      "key": "BFejhg2009160_CR36",
      "unstructured": "Lu QL, Rabinowitz A, Chen YC et al: Systemic delivery of antisense oligoribonucleotide restores dystrophin expression in body-wide skeletal muscles. Proc Natl Acad Sci USA 2005; 102: 198–203.",
      "volume": "102",
      "year": "2005"
    },
    {
      "DOI": "10.1002/jgm.1288",
      "author": "HA Heemskerk",
      "doi-asserted-by": "publisher",
      "first-page": "257",
      "journal-title": "J Gene Med",
      "key": "BFejhg2009160_CR37",
      "unstructured": "Heemskerk HA, De Winter CL, de Kimpe SJ et al: In vivo comparison of 2′-O-methyl phosphorothioate and morpholino antisense oligonucleotides for Duchenne muscular dystrophy exon skipping. J Gene Med 2009; 11: 257–266.",
      "volume": "11",
      "year": "2009"
    },
    {
      "DOI": "10.1016/j.nmd.2008.05.011",
      "author": "L Vitiello",
      "doi-asserted-by": "publisher",
      "first-page": "597",
      "journal-title": "Neuromuscul Disord",
      "key": "BFejhg2009160_CR38",
      "unstructured": "Vitiello L, Bassi N, Campagnolo P et al: In vivo delivery of naked antisense oligos in aged mdx mice: analysis of dystrophin restoration in skeletal and cardiac muscle. Neuromuscul Disord 2008; 18: 597–605.",
      "volume": "18",
      "year": "2008"
    },
    {
      "DOI": "10.1038/sj.mt.6300245",
      "author": "S Fletcher",
      "doi-asserted-by": "publisher",
      "first-page": "1587",
      "journal-title": "Mol Ther",
      "key": "BFejhg2009160_CR39",
      "unstructured": "Fletcher S, Honeyman K, Fall AM et al: Morpholino oligomer-mediated exon skipping averts the onset of dystrophic pathology in the mdx mouse. Mol Ther 2007; 15: 1587–1592.",
      "volume": "15",
      "year": "2007"
    },
    {
      "DOI": "10.1093/hmg/ddn293",
      "author": "H Yin",
      "doi-asserted-by": "publisher",
      "first-page": "3909",
      "journal-title": "Hum Mol Genet",
      "key": "BFejhg2009160_CR40",
      "unstructured": "Yin H, Moulton HM, Seow Y et al: Cell-penetrating peptide-conjugated antisense oligonucleotides restore systemic muscle and cardiac dystrophin expression and function. Hum Mol Genet 2008; 17: 3909–3918.",
      "volume": "17",
      "year": "2008"
    },
    {
      "DOI": "10.1038/mt.2008.120",
      "author": "N Jearawiriyapaisarn",
      "doi-asserted-by": "publisher",
      "first-page": "1624",
      "journal-title": "Mol Ther",
      "key": "BFejhg2009160_CR41",
      "unstructured": "Jearawiriyapaisarn N, Moulton HM, Buckley B et al: Sustained dystrophin expression induced by peptide-conjugated morpholino oligomers in the muscles of mdx mice. Mol Ther 2008; 16: 1624–1629.",
      "volume": "16",
      "year": "2008"
    },
    {
      "DOI": "10.1126/science.1104297",
      "author": "A Goyenvalle",
      "doi-asserted-by": "publisher",
      "first-page": "1796",
      "journal-title": "Science",
      "key": "BFejhg2009160_CR42",
      "unstructured": "Goyenvalle A, Vulin A, Fougerousse F et al: Rescue of dystrophic muscle through U7 snRNA-mediated exon skipping. Science 2004; 306: 1796–1799.",
      "volume": "306",
      "year": "2004"
    },
    {
      "DOI": "10.1073/pnas.0508917103",
      "author": "MA Denti",
      "doi-asserted-by": "publisher",
      "first-page": "3758",
      "journal-title": "Proc Natl Acad Sci USA",
      "key": "BFejhg2009160_CR43",
      "unstructured": "Denti MA, Rosa A, D'Antona G et al: Body-wide gene therapy of Duchenne muscular dystrophy in the mdx mouse model. Proc Natl Acad Sci USA 2006; 103: 3758–3763.",
      "volume": "103",
      "year": "2006"
    },
    {
      "DOI": "10.1089/hum.2008.012",
      "author": "MA Denti",
      "doi-asserted-by": "publisher",
      "first-page": "601",
      "journal-title": "Hum Gene Ther",
      "key": "BFejhg2009160_CR44",
      "unstructured": "Denti MA, Incitti T, Sthandier O et al: Long-term benefit of adeno-associated virus/antisense-mediated exon skipping in dystrophic mice. Hum Gene Ther 2008; 19: 601–608.",
      "volume": "19",
      "year": "2008"
    },
    {
      "DOI": "10.1038/sj.gt.3302984",
      "author": "K Yuasa",
      "doi-asserted-by": "publisher",
      "first-page": "1249",
      "journal-title": "Gene Therapy",
      "key": "BFejhg2009160_CR45",
      "unstructured": "Yuasa K, Yoshimura M, Urasawa N et al: Injection of a recombinant AAV serotype 2 into canine skeletal muscles evokes strong immune responses against transgene products. Gene Therapy 2007; 14: 1249–1260.",
      "volume": "14",
      "year": "2007"
    },
    {
      "DOI": "10.1038/gt.2008.54",
      "author": "AK Zaiss",
      "doi-asserted-by": "publisher",
      "first-page": "808",
      "journal-title": "Gene Therapy",
      "key": "BFejhg2009160_CR46",
      "unstructured": "Zaiss AK, Muruve DA : Immunity to adeno-associated virus vectors in animals and humans: a continued challenge. Gene Therapy 2008; 15: 808–816.",
      "volume": "15",
      "year": "2008"
    },
    {
      "DOI": "10.1038/gt.2008.65",
      "author": "JF Wright",
      "doi-asserted-by": "publisher",
      "first-page": "840",
      "journal-title": "Gene Therapy",
      "key": "BFejhg2009160_CR47",
      "unstructured": "Wright JF : Manufacturing and characterizing AAV-based vectors for use in clinical studies. Gene Therapy 2008; 15: 840–848.",
      "volume": "15",
      "year": "2008"
    },
    {
      "author": "GJ van Ommen",
      "first-page": "140",
      "journal-title": "Curr Opin Mol Ther",
      "key": "BFejhg2009160_CR48",
      "unstructured": "van Ommen GJ, van Deutekom J, Aartsma-Rus A : The therapeutic potential of antisense-mediated exon skipping. Curr Opin Mol Ther 2008; 10: 140–149.",
      "volume": "10",
      "year": "2008"
    },
    {
      "DOI": "10.1016/S0959-437X(02)00301-5",
      "author": "T Frugier",
      "doi-asserted-by": "publisher",
      "first-page": "294",
      "journal-title": "Curr Opin Genet Dev",
      "key": "BFejhg2009160_CR49",
      "unstructured": "Frugier T, Nicole S, Cifuentes-Diaz C, Melki J : The molecular bases of spinal muscular atrophy. Curr Opin Genet Dev 2002; 12: 294–298.",
      "volume": "12",
      "year": "2002"
    },
    {
      "DOI": "10.1016/0092-8674(95)90460-3",
      "author": "S Lefebvre",
      "doi-asserted-by": "publisher",
      "first-page": "155",
      "journal-title": "Cell",
      "key": "BFejhg2009160_CR50",
      "unstructured": "Lefebvre S, Burglen L, Reboullet S et al: Identification and characterization of a spinal muscular atrophy-determining gene. Cell 1995; 80: 155–165.",
      "volume": "80",
      "year": "1995"
    },
    {
      "DOI": "10.1038/nrm760",
      "author": "G Dreyfuss",
      "doi-asserted-by": "publisher",
      "first-page": "195",
      "journal-title": "Nat Rev Mol Cell Biol",
      "key": "BFejhg2009160_CR51",
      "unstructured": "Dreyfuss G, Kim VN, Kataoka N : Messenger-RNA-binding proteins and the messages they carry. Nat Rev Mol Cell Biol 2002; 3: 195–205.",
      "volume": "3",
      "year": "2002"
    },
    {
      "DOI": "10.1073/pnas.94.18.9920",
      "author": "B Schrank",
      "doi-asserted-by": "publisher",
      "first-page": "9920",
      "journal-title": "Proc Natl Acad Sci USA",
      "key": "BFejhg2009160_CR52",
      "unstructured": "Schrank B, Gotz R, Gunnersen JM et al: Inactivation of the survival motor neuron gene, a candidate gene for human spinal muscular atrophy, leads to massive cell death in early mouse embryos. Proc Natl Acad Sci USA 1997; 94: 9920–9925.",
      "volume": "94",
      "year": "1997"
    },
    {
      "DOI": "10.1038/ng0598-63",
      "author": "CL Lorson",
      "doi-asserted-by": "publisher",
      "first-page": "63",
      "journal-title": "Nat Genet",
      "key": "BFejhg2009160_CR53",
      "unstructured": "Lorson CL, Strasswimmer J, Yao JM et al: SMN oligomerization defect correlates with spinal muscular atrophy severity. Nat Genet 1998; 19: 63–66.",
      "volume": "19",
      "year": "1998"
    },
    {
      "DOI": "10.1073/pnas.96.11.6307",
      "author": "CL Lorson",
      "doi-asserted-by": "publisher",
      "first-page": "6307",
      "journal-title": "Proc Natl Acad Sci USA",
      "key": "BFejhg2009160_CR54",
      "unstructured": "Lorson CL, Hahnen E, Androphy EJ, Wirth B : A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy. Proc Natl Acad Sci USA 1999; 96: 6307–6311.",
      "volume": "96",
      "year": "1999"
    },
    {
      "DOI": "10.1093/hmg/8.7.1177",
      "author": "UR Monani",
      "doi-asserted-by": "publisher",
      "first-page": "1177",
      "journal-title": "Hum Mol Genet",
      "key": "BFejhg2009160_CR55",
      "unstructured": "Monani UR, Lorson CL, Parsons DW et al: A single nucleotide difference that alters splicing patterns distinguishes the SMA gene SMN1 from the copy gene SMN2. Hum Mol Genet 1999; 8: 1177–1183.",
      "volume": "8",
      "year": "1999"
    },
    {
      "DOI": "10.1097/00125817-200201000-00004",
      "author": "MD Mailman",
      "doi-asserted-by": "publisher",
      "first-page": "20",
      "journal-title": "Genet Med",
      "key": "BFejhg2009160_CR56",
      "unstructured": "Mailman MD, Heinz JW, Papp AC et al: Molecular analysis of spinal muscular atrophy and modification of the phenotype by SMN2. Genet Med 2002; 4: 20–26.",
      "volume": "4",
      "year": "2002"
    },
    {
      "DOI": "10.1073/pnas.171105098",
      "author": "JG Chang",
      "doi-asserted-by": "publisher",
      "first-page": "9808",
      "journal-title": "Proc Natl Acad Sci USA",
      "key": "BFejhg2009160_CR57",
      "unstructured": "Chang JG, Hsieh-Li HM, Jong YJ, Wang NM, Tsai CH, Li H : Treatment of spinal muscular atrophy by sodium butyrate. Proc Natl Acad Sci USA 2001; 98: 9808–9813.",
      "volume": "98",
      "year": "2001"
    },
    {
      "DOI": "10.1038/sj.gt.3301550",
      "author": "ML Zhang",
      "doi-asserted-by": "publisher",
      "first-page": "1532",
      "journal-title": "Gene Therapy",
      "key": "BFejhg2009160_CR58",
      "unstructured": "Zhang ML, Lorson CL, Androphy EJ, Zhou J : An in vivo reporter system for measuring increased inclusion of exon 7 in SMN2 mRNA: potential therapy of SMA. Gene Therapy 2001; 8: 1532–1538.",
      "volume": "8",
      "year": "2001"
    },
    {
      "DOI": "10.1093/hmg/10.24.2841",
      "author": "C Andreassi",
      "doi-asserted-by": "publisher",
      "first-page": "2841",
      "journal-title": "Hum Mol Genet",
      "key": "BFejhg2009160_CR59",
      "unstructured": "Andreassi C, Jarecki J, Zhou J et al: Aclarubicin treatment restores SMN levels to cells derived from type I spinal muscular atrophy patients. Hum Mol Genet 2001; 10: 2841–2849.",
      "volume": "10",
      "year": "2001"
    },
    {
      "DOI": "10.1002/ana.10743",
      "author": "CJ Sumner",
      "doi-asserted-by": "publisher",
      "first-page": "647",
      "journal-title": "Ann Neurol",
      "key": "BFejhg2009160_CR60",
      "unstructured": "Sumner CJ, Huynh TN, Markowitz JA et al: Valproic acid increases SMN levels in spinal muscular atrophy patient cells. Ann Neurol 2003; 54: 647–654.",
      "volume": "54",
      "year": "2003"
    },
    {
      "DOI": "10.1038/ng854",
      "author": "L Cartegni",
      "doi-asserted-by": "publisher",
      "first-page": "377",
      "journal-title": "Nat Genet",
      "key": "BFejhg2009160_CR61",
      "unstructured": "Cartegni L, Krainer AR : Disruption of an SF2/ASF-dependent exonic splicing enhancer in SMN2 causes spinal muscular atrophy in the absence of SMN1. Nat Genet 2002; 30: 377–384.",
      "volume": "30",
      "year": "2002"
    },
    {
      "DOI": "10.1038/ng1207",
      "author": "T Kashima",
      "doi-asserted-by": "publisher",
      "first-page": "460",
      "journal-title": "Nat Genet",
      "key": "BFejhg2009160_CR62",
      "unstructured": "Kashima T, Manley JL : A negative element in SMN2 exon 7 inhibits splicing in spinal muscular atrophy. Nat Genet 2003; 34: 460–463.",
      "volume": "34",
      "year": "2003"
    },
    {
      "DOI": "10.1073/pnas.0700343104",
      "author": "T Kashima",
      "doi-asserted-by": "publisher",
      "first-page": "3426",
      "journal-title": "Proc Natl Acad Sci USA",
      "key": "BFejhg2009160_CR63",
      "unstructured": "Kashima T, Rao N, Manley JL : An intronic element contributes to splicing repression in spinal muscular atrophy. Proc Natl Acad Sci USA 2007; 104: 3426–3431.",
      "volume": "104",
      "year": "2007"
    },
    {
      "DOI": "10.1074/jbc.M209271200",
      "author": "H Miyaso",
      "doi-asserted-by": "publisher",
      "first-page": "15825",
      "journal-title": "J Biol Chem",
      "key": "BFejhg2009160_CR64",
      "unstructured": "Miyaso H, Okumura M, Kondo S, Higashide S, Miyajima H, Imaizumi K : An intronic splicing enhancer element in survival motor neuron (SMN) pre-mRNA. J Biol Chem 2003; 278: 15825–15831.",
      "volume": "278",
      "year": "2003"
    },
    {
      "DOI": "10.1074/jbc.M200851200",
      "author": "H Miyajima",
      "doi-asserted-by": "publisher",
      "first-page": "23271",
      "journal-title": "J Biol Chem",
      "key": "BFejhg2009160_CR65",
      "unstructured": "Miyajima H, Miyaso H, Okumura M, Kurisu J, Imaizumi K : Identification of a cis-acting element for the regulation of SMN exon 7 splicing. J Biol Chem 2002; 277: 23271–23277.",
      "volume": "277",
      "year": "2002"
    },
    {
      "DOI": "10.1261/rna.7580704",
      "author": "NN Singh",
      "doi-asserted-by": "publisher",
      "first-page": "1291",
      "journal-title": "RNA",
      "key": "BFejhg2009160_CR66",
      "unstructured": "Singh NN, Androphy EJ, Singh RN : In vivo selection reveals combinatorial controls that define a critical exon in the spinal muscular atrophy genes. RNA 2004; 10: 1291–1305.",
      "volume": "10",
      "year": "2004"
    },
    {
      "DOI": "10.1016/j.bbrc.2004.01.067",
      "author": "NN Singh",
      "doi-asserted-by": "publisher",
      "first-page": "381",
      "journal-title": "Biochem Biophys Res Commun",
      "key": "BFejhg2009160_CR67",
      "unstructured": "Singh NN, Androphy EJ, Singh RN : An extended inhibitory context causes skipping of exon 7 of SMN2 in spinal muscular atrophy. Biochem Biophys Res Commun 2004; 315: 381–388.",
      "volume": "315",
      "year": "2004"
    },
    {
      "DOI": "10.4161/rna.4.1.4535",
      "author": "RN Singh",
      "doi-asserted-by": "publisher",
      "first-page": "7",
      "journal-title": "RNA Biol",
      "key": "BFejhg2009160_CR68",
      "unstructured": "Singh RN : Evolving concepts on human SMN pre-mRNA splicing. RNA Biol 2007; 4: 7–10.",
      "volume": "4",
      "year": "2007"
    },
    {
      "DOI": "10.1128/MCB.26.4.1333-1346.2006",
      "author": "NK Singh",
      "doi-asserted-by": "publisher",
      "first-page": "1333",
      "journal-title": "Mol Cell Biol",
      "key": "BFejhg2009160_CR69",
      "unstructured": "Singh NK, Singh NN, Androphy EJ, Singh RN : Splicing of a critical exon of human Survival Motor Neuron is regulated by a unique silencer element located in the last intron. Mol Cell Biol 2006; 26: 1333–1346.",
      "volume": "26",
      "year": "2006"
    },
    {
      "DOI": "10.1074/jbc.M107632200",
      "author": "SR Lim",
      "doi-asserted-by": "publisher",
      "first-page": "45476",
      "journal-title": "J Biol Chem",
      "key": "BFejhg2009160_CR70",
      "unstructured": "Lim SR, Hertel KJ : Modulation of survival motor neuron pre-mRNA splicing by inhibition of alternative 3′ splice site pairing. J Biol Chem 2001; 276: 45476–45483.",
      "volume": "276",
      "year": "2001"
    },
    {
      "DOI": "10.1016/j.ymthe.2005.08.022",
      "author": "C Madocsai",
      "doi-asserted-by": "publisher",
      "first-page": "1013",
      "journal-title": "Mol Ther",
      "key": "BFejhg2009160_CR71",
      "unstructured": "Madocsai C, Lim SR, Geib T, Lam BJ, Hertel KJ : Correction of SMN2 Pre-mRNA splicing by antisense U7 small nuclear RNAs. Mol Ther 2005; 12: 1013–1022.",
      "volume": "12",
      "year": "2005"
    },
    {
      "DOI": "10.1089/hgt.2008.067",
      "doi-asserted-by": "crossref",
      "key": "BFejhg2009160_CR72",
      "unstructured": "Dickson A, Osman E, Lorson C : A Negatively-Acting Bifunctional RNA Increases Survival Motor Neuron in vitro and in vivo. Hum Gene Ther 2008; 25 August [e-pub ahead of print]."
    },
    {
      "DOI": "10.1038/nsb887",
      "author": "L Cartegni",
      "doi-asserted-by": "publisher",
      "first-page": "120",
      "journal-title": "Nat Struct Biol",
      "key": "BFejhg2009160_CR73",
      "unstructured": "Cartegni L, Krainer AR : Correction of disease-associated exon skipping by synthetic exon-specific activators. Nat Struct Biol 2003; 10: 120–125.",
      "volume": "10",
      "year": "2003"
    },
    {
      "DOI": "10.1073/pnas.0633863100",
      "author": "LA Skordis",
      "doi-asserted-by": "publisher",
      "first-page": "4114",
      "journal-title": "Proc Natl Acad Sci USA",
      "key": "BFejhg2009160_CR74",
      "unstructured": "Skordis LA, Dunckley MG, Yue B, Eperon IC, Muntoni F : Bifunctional antisense oligonucleotides provide a trans-acting splicing enhancer that stimulates SMN2 gene expression in patient fibroblasts. Proc Natl Acad Sci USA 2003; 100: 4114–4119.",
      "volume": "100",
      "year": "2003"
    },
    {
      "DOI": "10.1016/j.ymthe.2006.01.012",
      "author": "T Baughan",
      "doi-asserted-by": "publisher",
      "first-page": "54",
      "journal-title": "Mol Ther",
      "key": "BFejhg2009160_CR75",
      "unstructured": "Baughan T, Shababi M, Coady TH, Dickson AM, Tullis GE, Lorson CL : Stimulating full-length SMN2 expression by delivering bifunctional RNAs via a viral vector. Mol Ther 2006; 14: 54–62.",
      "volume": "14",
      "year": "2006"
    },
    {
      "DOI": "10.1038/sj.mt.6300200",
      "author": "J Marquis",
      "doi-asserted-by": "publisher",
      "first-page": "1479",
      "journal-title": "Mol Ther",
      "key": "BFejhg2009160_CR76",
      "unstructured": "Marquis J, Meyer K, Angehrn L, Kampfer SS, Rothen-Rutishauser B, Schumperli D : Spinal Muscular Atrophy: SMN2 Pre-mRNA Splicing Corrected by a U7 snRNA Derivative Carrying a Splicing Enhancer Sequence. Mol Ther 2007; 15: 1479–1486.",
      "volume": "15",
      "year": "2007"
    },
    {
      "DOI": "10.1038/gt.2008.138",
      "author": "J Marquis",
      "doi-asserted-by": "publisher",
      "first-page": "70",
      "journal-title": "Gene Therapy",
      "key": "BFejhg2009160_CR77",
      "unstructured": "Marquis J, Kampfer SS, Angehrn L, Schumperli D : Doxycycline-controlled splicing modulation by regulated antisense U7 snRNA expression cassettes. Gene Therapy 2009; 16: 70–77.",
      "volume": "16",
      "year": "2009"
    },
    {
      "DOI": "10.1093/hmg/ddn382",
      "author": "K Meyer",
      "doi-asserted-by": "publisher",
      "first-page": "546",
      "journal-title": "Hum Mol Genet",
      "key": "BFejhg2009160_CR78",
      "unstructured": "Meyer K, Marquis J, Trub J et al: Rescue of a severe mouse model for spinal muscular atrophy by U7 snRNA-mediated splicing modulation. Hum Mol Genet 2009; 18: 546–555.",
      "volume": "18",
      "year": "2009"
    },
    {
      "DOI": "10.1126/science.1589758",
      "author": "CT Caskey",
      "doi-asserted-by": "publisher",
      "first-page": "784",
      "journal-title": "Science",
      "key": "BFejhg2009160_CR79",
      "unstructured": "Caskey CT, Pizzuti A, Fu YH, Fenwick Jr RG, Nelson DL : Triplet repeat mutations in human disease. Science 1992; 256: 784–789.",
      "volume": "256",
      "year": "1992"
    },
    {
      "DOI": "10.1002/mus.20301",
      "author": "L Machuca-Tzili",
      "doi-asserted-by": "publisher",
      "first-page": "1",
      "journal-title": "Muscle Nerve",
      "key": "BFejhg2009160_CR80",
      "unstructured": "Machuca-Tzili L, Brook D, Hilton-Jones D : Clinical and molecular aspects of the myotonic dystrophies: a review. Muscle Nerve 2005; 32: 1–18.",
      "volume": "32",
      "year": "2005"
    },
    {
      "DOI": "10.1126/science.1062125",
      "author": "CL Liquori",
      "doi-asserted-by": "publisher",
      "first-page": "864",
      "journal-title": "Science",
      "key": "BFejhg2009160_CR81",
      "unstructured": "Liquori CL, Ricker K, Moseley ML et al: Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9. Science 2001; 293: 864–867.",
      "volume": "293",
      "year": "2001"
    },
    {
      "author": "JD Brook",
      "first-page": "385",
      "journal-title": "Cell",
      "key": "BFejhg2009160_CR82",
      "unstructured": "Brook JD, McCurrach ME, Harley HG et al: Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member. Cell 1992; 69: 385.",
      "volume": "69",
      "year": "1992"
    },
    {
      "DOI": "10.1016/j.bbadis.2006.05.013",
      "author": "DH Cho",
      "doi-asserted-by": "publisher",
      "first-page": "195",
      "journal-title": "Biochim Biophys Acta",
      "key": "BFejhg2009160_CR83",
      "unstructured": "Cho DH, Tapscott SJ : Myotonic dystrophy: emerging mechanisms for DM1 and DM2. Biochim Biophys Acta 2007; 1772: 195–204.",
      "volume": "1772",
      "year": "2007"
    },
    {
      "DOI": "10.1083/jcb.128.6.995",
      "author": "KL Taneja",
      "doi-asserted-by": "publisher",
      "first-page": "995",
      "journal-title": "J Cell Biol",
      "key": "BFejhg2009160_CR84",
      "unstructured": "Taneja KL, McCurrach M, Schalling M, Housman D, Singer RH : Foci of trinucleotide repeat transcripts in nuclei of myotonic dystrophy cells and tissues. J Cell Biol 1995; 128: 995–1002.",
      "volume": "128",
      "year": "1995"
    },
    {
      "DOI": "10.1093/hmg/11.7.805",
      "author": "M Fardaei",
      "doi-asserted-by": "publisher",
      "first-page": "805",
      "journal-title": "Hum Mol Genet",
      "key": "BFejhg2009160_CR85",
      "unstructured": "Fardaei M, Rogers MT, Thorpe HM et al: Three proteins, MBNL, MBLL and MBXL, co-localize in vivo with nuclear foci of expanded-repeat transcripts in DM1 and DM2 cells. Hum Mol Genet 2002; 11: 805–814.",
      "volume": "11",
      "year": "2002"
    },
    {
      "DOI": "10.1126/science.280.5364.737",
      "author": "AV Philips",
      "doi-asserted-by": "publisher",
      "first-page": "737",
      "journal-title": "Science",
      "key": "BFejhg2009160_CR86",
      "unstructured": "Philips AV, Timchenko LT, Cooper TA : Disruption of splicing regulated by a CUG-binding protein in myotonic dystrophy. Science 1998; 280: 737–741.",
      "volume": "280",
      "year": "1998"
    },
    {
      "DOI": "10.1038/ejhg.2008.227",
      "author": "RP Junghans",
      "doi-asserted-by": "publisher",
      "first-page": "543",
      "journal-title": "Eur J Hum Genet",
      "key": "BFejhg2009160_CR87",
      "unstructured": "Junghans RP : Dystrophia myotonia: why focus on foci? Eur J Hum Genet 2009; 17: 543–553.",
      "volume": "17",
      "year": "2009"
    },
    {
      "DOI": "10.1016/S1097-2765(02)00572-5",
      "author": "B Charlet",
      "doi-asserted-by": "publisher",
      "first-page": "45",
      "journal-title": "Mol Cell",
      "key": "BFejhg2009160_CR88",
      "unstructured": "Charlet B, Savkur RS, Singh G, Philips AV, Grice EA, Cooper TA : Loss of the muscle-specific chloride channel in type 1 myotonic dystrophy due to misregulated alternative splicing. Mol Cell 2002; 10: 45–53.",
      "volume": "10",
      "year": "2002"
    },
    {
      "DOI": "10.1086/421528",
      "author": "RS Savkur",
      "doi-asserted-by": "publisher",
      "first-page": "1309",
      "journal-title": "Am J Hum Genet",
      "key": "BFejhg2009160_CR89",
      "unstructured": "Savkur RS, Philips AV, Cooper TA et al: Insulin receptor splicing alteration in myotonic dystrophy type 2. Am J Hum Genet 2004; 74: 1309–1313.",
      "volume": "74",
      "year": "2004"
    },
    {
      "DOI": "10.1016/S1097-2765(02)00563-4",
      "author": "A Mankodi",
      "doi-asserted-by": "publisher",
      "first-page": "35",
      "journal-title": "Mol Cell",
      "key": "BFejhg2009160_CR90",
      "unstructured": "Mankodi A, Takahashi MP, Jiang H et al: Expanded CUG repeats trigger aberrant splicing of ClC-1 chloride channel pre-mRNA and hyperexcitability of skeletal muscle in myotonic dystrophy. Mol Cell 2002; 10: 35–44.",
      "volume": "10",
      "year": "2002"
    },
    {
      "DOI": "10.1126/science.1088583",
      "author": "RN Kanadia",
      "doi-asserted-by": "publisher",
      "first-page": "1978",
      "journal-title": "Science",
      "key": "BFejhg2009160_CR91",
      "unstructured": "Kanadia RN, Johnstone KA, Mankodi A et al: A muscleblind knockout model for myotonic dystrophy. Science 2003; 302: 1978–1980.",
      "volume": "302",
      "year": "2003"
    },
    {
      "DOI": "10.1085/jgp.200609635",
      "author": "JD Lueck",
      "doi-asserted-by": "publisher",
      "first-page": "79",
      "journal-title": "J Gen Physiol",
      "key": "BFejhg2009160_CR92",
      "unstructured": "Lueck JD, Mankodi A, Swanson MS, Thornton CA, Dirksen RT : Muscle chloride channel dysfunction in two mouse models of myotonic dystrophy. J Gen Physiol 2007; 129: 79–94.",
      "volume": "129",
      "year": "2007"
    },
    {
      "DOI": "10.1006/bbrc.1996.0668",
      "author": "U Galderisi",
      "doi-asserted-by": "publisher",
      "first-page": "750",
      "journal-title": "Biochem Biophys Res Commun",
      "key": "BFejhg2009160_CR93",
      "unstructured": "Galderisi U, Cipollaro M, Melone MA et al: Myotonic dystrophy: antisense oligonucleotide inhibition of DMPK gene expression in vitro. Biochem Biophys Res Commun 1996; 221: 750–754.",
      "volume": "221",
      "year": "1996"
    },
    {
      "DOI": "10.1126/science.1173110",
      "author": "TM Wheeler",
      "doi-asserted-by": "publisher",
      "first-page": "336",
      "journal-title": "Science",
      "key": "BFejhg2009160_CR94",
      "unstructured": "Wheeler TM, Sobczak K, Lueck JD et al: Reversal of RNA dominance by displacement of protein sequestered on triplet repeat RNA. Science 2009; 325: 336–339.",
      "volume": "325",
      "year": "2009"
    },
    {
      "DOI": "10.1001/jama.280.10.871-JMN0909-6-1",
      "author": "C Marwick",
      "doi-asserted-by": "publisher",
      "first-page": "871",
      "journal-title": "JAMA",
      "key": "BFejhg2009160_CR95",
      "unstructured": "Marwick C : First ‘antisense’ drug will treat CMV retinitis. JAMA 1998; 280: 871.",
      "volume": "280",
      "year": "1998"
    },
    {
      "DOI": "10.1002/jcb.20790",
      "author": "WH Pan",
      "doi-asserted-by": "publisher",
      "first-page": "14",
      "journal-title": "J Cell Biochem",
      "key": "BFejhg2009160_CR96",
      "unstructured": "Pan WH, Clawson GA : Antisense applications for biological control. J Cell Biochem 2006; 98: 14–35.",
      "volume": "98",
      "year": "2006"
    },
    {
      "author": "A Dorn",
      "first-page": "10",
      "journal-title": "Curr Opin Mol Ther",
      "key": "BFejhg2009160_CR97",
      "unstructured": "Dorn A, Kippenberger S : Clinical application of CpG-, non-CpG-, and antisense oligodeoxynucleotides as immunomodulators. Curr Opin Mol Ther 2008; 10: 10–20.",
      "volume": "10",
      "year": "2008"
    },
    {
      "DOI": "10.1016/j.drudis.2008.03.014",
      "author": "ER Rayburn",
      "doi-asserted-by": "publisher",
      "first-page": "513",
      "journal-title": "Drug Discov Today",
      "key": "BFejhg2009160_CR98",
      "unstructured": "Rayburn ER, Zhang R : Antisense, RNAi, and gene silencing strategies for therapy: mission possible or impossible? Drug Discov Today 2008; 13: 513–521.",
      "volume": "13",
      "year": "2008"
    },
    {
      "DOI": "10.1038/79951",
      "author": "A Nasevicius",
      "doi-asserted-by": "publisher",
      "first-page": "216",
      "journal-title": "Nat Genet",
      "key": "BFejhg2009160_CR99",
      "unstructured": "Nasevicius A, Ekker SC : Effective targeted gene ‘knockdown’ in zebrafish. Nat Genet 2000; 26: 216–220.",
      "volume": "26",
      "year": "2000"
    },
    {
      "DOI": "10.2741/2697",
      "author": "C Bertoni",
      "doi-asserted-by": "publisher",
      "first-page": "517",
      "journal-title": "Front Biosci",
      "key": "BFejhg2009160_CR100",
      "unstructured": "Bertoni C : Clinical approaches in the treatment of Duchenne muscular dystrophy (DMD) using oligonucleotides. Front Biosci 2008; 13: 517–527.",
      "volume": "13",
      "year": "2008"
    }
  ],
  "reference-count": 100,
  "references-count": 100,
  "resource": {
    "primary": {
      "URL": "https://www.nature.com/articles/ejhg2009160"
    }
  },
  "score": 0,
  "short-container-title": [
    "Eur J Hum Genet"
  ],
  "source": "Crossref",
  "title": [
    "Progress in therapeutic antisense applications for neuromuscular disorders"
  ],
  "type": "journal-article",
  "volume": "18"
}